Ranking Profile - Aravive Inc
Introduction
Aravive Inc (Aravive), formerly Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of life-threatening diseases. The company’s lead product candidate include batiraxcept (AVB-500), binds to GAS6 and prevents AXL signaling to inhibit metastasis, tumor growth and restore sensitivity to anti-cancer agents. Its product treats ovarian cancer, clear cell renal cancer, pancreatic adenocarcinoma, and fibrosis. The company partners with WuXi Biologics Limited and 3D Medicines Inc., in China, Taiwan, Hong Kong and Macau to prevent human oncological diseases. Aravive is headquartered in Houston, Texas, the US.
Company info
| Country (HQ): | United States |
| Sector: | Pharmaceuticals and Healthcare |
| Market Cap (US$ m): | 98 |
| Revenue (US$ m): | 9 (2022) |
Innovation ranking
Innovation score
Closest peers in the Pharmaceuticals and Healthcare sector
Innovation Ranking
Johnson & Johnson
United States
Pharmaceuticals and Healthcare
F. Hoffmann-La Roche Ltd
Switzerland
Pharmaceuticals and Healthcare
Aravive Inc
United States
Pharmaceuticals and Healthcare
EyeGate Pharmaceuticals Inc
United States
Pharmaceuticals and Healthcare
Shin Poong Pharm Co Ltd
South Korea
Pharmaceuticals and Healthcare
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release
